Amarillo Biosciences, Inc. (OTCMKTS:AMAR – Get Free Report) shares were down 14.3% during mid-day trading on Monday . The stock traded as low as $0.60 and last traded at $0.60. Approximately 6,100 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 18,253 shares. The stock had previously closed at $0.70.
Amarillo Biosciences Stock Down 14.3 %
The firm has a fifty day moving average of $0.60.
About Amarillo Biosciences
Amarillo Biosciences, Inc, a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases.
See Also
- Five stocks we like better than Amarillo Biosciences
- How to Evaluate a Stock Before Buying
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- When to Sell a Stock for Profit or Loss
- 3 Value Stocks You Can Buy Before They Become Big
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20221209114501&h=45&w=95&zc=2){kind=logo}
